Suppr超能文献

[自身免疫性甲状腺疾病中的甲状腺内淋巴细胞]

[Intrathyroidal lymphocytes in autoimmune thyroid diseases].

作者信息

Aguayo J, Wohlik N, Baeza A, Carrasco A M, Pineda G

机构信息

Departamento de Medicina, Hospital Salvador, Universidad de Chile (Campus Oriente).

出版信息

Rev Med Chil. 1994 Jan;122(1):19-26.

PMID:8066339
Abstract

Aiming to assess the autoimmune origin of certain thyroid diseases, we studied the phenotypic composition and the ability of intrathyroidal lymphocytes to a re-induce HLA-DR expression on autologous thyrocytes coming from patients with graves's disease, nodular goiter and papillary thyroid carcinoma. Lymphocytes coming only from graves's disease patients were capable of reinduce HLA-DR expression on autologous thyrocytes (24.1 +/- 13.6 vs 1.5 +/- 2.54% in nodular goiter and carcinoma), as interferon gamma did (17.4 +/- 8.34%). Phenotypic characterization showed a significant decrease of T-CD3 (total lymphocytes) and T-CD4 (helper) in lymphocytes coming from patients with nodular goiter and carcinoma, and a marked reduction of T-CD8 (suppressor) in lymphocytes coming from patients with graves disease. Thus the T-CD4/T-CD8 ratio varies according to the etiology of the thyroidal disease. The lack of suppressor activity would explain why cells coming only from patients with graves disease, show marked HLA-DR expression. These findings give little support to the autoimmune origin hypothesis for nodular goiter and thyroid carcinoma.

摘要

为了评估某些甲状腺疾病的自身免疫起源,我们研究了甲状腺内淋巴细胞的表型组成以及其重新诱导来自格雷夫斯病、结节性甲状腺肿和甲状腺乳头状癌患者的自体甲状腺细胞上 HLA - DR 表达的能力。仅来自格雷夫斯病患者的淋巴细胞能够重新诱导自体甲状腺细胞上的 HLA - DR 表达(24.1±13.6,而结节性甲状腺肿和癌患者中为 1.5±2.54%),干扰素γ也能如此(17.4±8.34%)。表型特征显示,来自结节性甲状腺肿和癌患者的淋巴细胞中 T - CD3(总淋巴细胞)和 T - CD4(辅助性 T 细胞)显著减少,而来自格雷夫斯病患者的淋巴细胞中 T - CD8(抑制性 T 细胞)明显减少。因此,T - CD4/T - CD8 比值根据甲状腺疾病的病因不同而变化。抑制活性的缺乏可以解释为什么仅来自格雷夫斯病患者的细胞显示出明显的 HLA - DR 表达。这些发现几乎不支持结节性甲状腺肿和甲状腺癌的自身免疫起源假说。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验